Search Results

to podcast list Strategic Partner(s) When to Walk, When to Run: Lessons from the GPCR Trenches with Dr Host Dr. About Ben Clements Dr. Dr. Pharmacology Corner ✔ Advanced GPCR courses ✔ Scientific discussions → Become Premium Enjoying the Dr

lipid rafts, bitter taste receptor pharmacology, and data integration in this expert interview with Dr to podcast list Strategic Partner(s) How Lipid Rafts Organize GPCR Signaling This episode features Dr Dr. For more on advanced topics in GPCR drug discovery and methods, browse additional episodes at Dr. Dr.

In this conversation, Dr. Dr. About the Guest Dr. Welcome to the Dr. GPCR podcast. My guest today is Dr.

GPCR pharmacologist Dr. Dr. For Dr. Dr. Dr. Arun Shukla on the web Indian Institute of Technology Dr.

Dr. Dr. Dr. Dr. Dr.

Strategic Partner(s) GPCR Assay Strategy, Bias, and Translational Drug Discovery This episode features Dr Dr. Dr. About Martin Marro Dr. Dr.

Dr. For Dr. J. Two of Dr. For Dr. Dr. J. Silvio Gutkind on the web Dr.

Learn all about the content guidelines for Dr. GPCR Ecosystem website. Content and Conduct Policy Dr. GPCR, Corp, LLC (“Dr. GPCR”) provides its Service to you through our websites referred to as Dr. Please read carefully our Legal Policies and Disclaimers to understand how Dr.

Access expert CRO advisory services through the Dr. GPCR Ecosystem. Get in touch Connect LinkedIn Podcast Dr. GPCR Calendly ©2023-2025 All rights reserved by FindYooour, LLC & Dr.

Dr. For Dr. In Dr. Dr. Dr. Graciela Pineyro on the web Dr. Graciela Pineyro on LinkedIn Dr.

When his lab closed in 2020, Dr. About the Guest Dr. Dr. Paul Insel "It's still about GPCRs." — Dr. Paul Insel About this episode Dr. Dr.

Explore how GPCR signaling shapes mosquito feeding and mating behaviors with Dr. Laura Duvall. Partner(s) Why Mosquitoes Hunt You: GPCR Control of Blood Feeding and Mating This episode features Dr Dr. GPCR Podcast and consider the expanded content on Dr. GPCR University . Why This Matters? In 2019, Dr.

Dr. Dr. Dr. Dr. Dr.

Dr. Dr. For Dr. Dr. Dr.

Dr. Dr. For Dr. Dr. Dr.

As the founder of Dr. Get in touch Connect LinkedIn Podcast Dr. GPCR Calendly ©2023-2025 All rights reserved by FindYooour, LLC & Dr.

Dr. We have also confirmed Dr.

Dr. Dr. About the Guest Dr. Dr. Dr.

See live sessions → What others are saying Dr. Hoare is very experienced in the field. I will keep Dr. I wish Dr. Also super-valuable for those of us learning how to teach pharmacology GPCR researcher Dr. Thoroughly enjoyed learning from him GPCR researcher Dr. Kenakin is a leading expert in the field.

In this episode, Dr. Dr. development models Anyone curious about where AI meets molecular pharmacology About Ajay Yekkirala Dr That “failure” became a launchpad: Ajay later joined the lab of Dr. Upcoming Live Expert Sessions ➚ 🔒Explore the Full Masterclass ➚ Unlock the Full Dr.

Dr. About the Guest Dr. Dr. About this episode Dr. Maria Waldhoer is originally from Austria. Dr. Maria Waldhoer on the web LinkedIn InterAx Biotech Pubmed Dr.

Dr. But a microarray Dr. When Dr. Dr. Dr.

Dr. About the Guest Dr. When Dr. Dr. Dr.

About the Panelists Dr. Dr. Aurélien Rizk is Chief Technology Officer at InterAx Biotech. Dr. Dr. Dr. Yamina Berchiche on the web Website LinkedIn Publications Twitter Facebook Dr.

Get in touch Connect LinkedIn Podcast Dr. GPCR Calendly ©2023-2025 All rights reserved by FindYooour, LLC & Dr.

Discover how Dr. Tom Sakmar and Dr. ) Hacking GPCRs: Tools, Tech & Drug Discovery with Tom Sakmar & Ilana Kotliar In this episode, host Dr Yamina Berchiche reconnects with Dr. Tom Sakmar , Professor at Rockefeller University, and Dr. A Long-Term Vision Realized “We've done this work for the past 30 years.” – Tom Sakmar Dr. I want to take it forward.” – Ilana Kotliar Dr.

Dr. Dr. About the Guest Dr. About this episode In this episode of the Dr. GPCR Podcast , I spoke to Dr. Dr.

In this episode of the Dr. series produced in collaboration with our partners at Celtarys Research . 🎧 Listen to Part 1 with Dr Hudson 🎧 Catch up on Part 2 with Dr. Broichhagen About the Guests Maria Majellaro, PhD Dr. Johannes Broichhagen, PhD Dr. David Hodson, PhD Dr.

Join Dr. GPCR Ecosystem and promote a positive online community. Content and Conduct Policy Dr. GPCR, Corp, LLC (“Dr. GPCR”) provides its Service to you through our websites referred to as Dr. Please read carefully our Legal Policies and Disclaimers to understand how Dr.

Your One-Stop-Shop for GPCR Drug Discovery and Development Researchers developing GPCR-targeted therapeutics need a reliable, comprehensive partner that spans discovery, optimization, and regulatory submission. Eurofins DiscoverX leads GPCR research innovation with 25+ years of expertise and provides you with product solutions including cell-based assays for basic research through therapeutic discovery and development. The assays are validated and accepted by industry and the scientific community, with thousands of peer-reviewed publications and billions of data points screened. These industry-standard assays, designed for regulatory submissions, are backed by partnerships with leading pharma and biotech companies worldwide. GPCR Product Solutions Determine rank-order hits, evaluate ligand bias or allostery, study multiple targets and signaling pathways, investigate target species variations, deorphanize receptors, and more Perform target identification and validation, high-throughput screening (HTS), lead optimization, safety assessment, and regulatory potency testing for commercial release Access a complete toolkit for GPCR solutions: cell line assay kits, cell lines, ready-to-use assays, detection kits, custom products, and more Comprehensive Coverage >1500 Human GPCRs products, including: 90% Target coverage Orphan receptors Ortholog variants Multiple cell line backgrounds Multiple Mechanisms of Actions (MOA) cAMP accumulation β-Arrestin recruitment Receptor internalization Ligand binding Calcium flux Pharmaco Chaperone discovery Numerous Product Types Cell line assay kits Cell lines Qualified bioassays eXpress assay kits Membrane preps Detection kits Custom products Services Flexible Formats for Every Research Need Eurofins DiscoverX understands that different research stages require different tools. This comprehensive portfolio offers multiple product formats to match your exact needs, whether you're conducting exploratory screens or regulatory-compliant potency testing. Assay Principle of Eurofins DiscoverX Cell-based Assays Whether you are developing small-molecule or biologic therapeutic drugs, Eurofins DiscoverX provides you with a variety of drug discovery and development products with multiple assay types and applications to meet your specific GPCR research needs. Access Product Solutions and Key Resources GPCR Functional Cell-Based Assays - Assessing Biased Signaling of Agonist Access White Paper Discover Your GPCR Solution - Find The Assay for Your Target of Interest Find Your Solutions The Human GPCRome - Obtain Your FREE Wall Poster for Your Laboratory Obtain Wall Poster Access GPCR Cell Line Assays, Ready-to-Use Kits, Mem Preps, & More Shop Products Supporting GPCR-focused Obesity and Diabetes Research Eurofins DiscoverX supports the ongoing obesity/diabetes revolution with the most comprehensive, validated portfolio for obesity and diabetes GPCR targets, including GLP-1, GIP, GCG, MC4, PYY, AMY receptors, and more. Browse products related to your obesity/diabetes target of interest: CALCRL and RAMP (AMs) GIPR GLP-1R GLP-2R GCGR GPR75 MC4R NPY2R (PYY) SSTR5 Activins CALCR and RAMPs (AMYs) Apelin (APJ/AGTRL1) View representative data: GLP-1R multi-MOA profiling Eurofins DiscoverX's GLP-1 receptor (GLP-1R) assay portfolio illustrates a comprehensive approach to obesity research, with complete MOA coverage for a single target: GLP-1. These assays enable complete pharmacological profiling across cAMP, β-arrestin, and internalization. GLP-1R representative assay results (dose-response curves) for exendin-4, tirzepatide, and retatrutide. A. cAMP dose–response; B. β-arrestin recruitment showing ligand bias; and C. Internalization profiles distinguishing highly versus weakly internalizing agonists. Together, these datasets exemplify the depth of pharmacological insight enabled by Eurofins DiscoverX platforms. This multi-dimensional characterization extends across our full obesity and diabetes product portfolio, including GIPR, GCGR, AMY receptors, MC4R, and beyond. Access GPCR Obesity and Diabetes Solutions and Key Resources Discover GPCR Obesity and Diabetes Product Solutions Find Your Solution Review GIP Product Solutions to Support Obesity/Diabetes View GIP Solutions Explore GLP-1 Product Solutions to Support Obesity/Diabetes See GLP-1 Solutions Accelerating Obesity Therapeutics Development Download App Note Beyond Eurofins DiscoverX Products: The Full Power of Eurofins Discovery Eurofins DiscoverX cell lines, assays, kits, and custom product solutions represent the foundation of tools for GPCR research and drug discovery and development. When these product solutions are combined with Calixar GPCR membrane proteins and Eurofins Discovery GPCR services, the benefits from integration provide the most comprehensive GPCR research and drug discovery platform spanning the entire discovery and development continuum. Eurofins Discovery GPCR services provides the industry's most extensive collection of validated GPCR assays with hundreds of binding and functional assays, available individually or in panels. These assays use the same platform as the Eurofins DiscoverX assays and beyond. Calixar GPCR membrane proteins , as a service, provides a wide array of GPCRs from various species, purified to the highest standards to ensure purity, integrity, and biological activity. These GPCRs are excellent for use in functional, structural, or identification assays. Let us Help You Get Started! Contact us Visit GPCR Product Solutions